← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2014Last known activity
Dec 15, 2025
Timeline
2010s
- Mar 1, 2014
NRG Oncology— Founded
Drugs by trial phase (162 distinct, 219 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (85 own, 0 via acquisition)
Phase 2 (66 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Mucinous
- Adenocarcinoma of Lung
- Adenomyoepithelioma
- Adenosarcoma
- Anus Neoplasms
- Astrocytoma
- Brain Neoplasms
- Breast Carcinoma In Situ
- Breast Neoplasms
- Brenner Tumor
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma, Adenosquamous
- Carcinoma, Ductal
- Carcinoma, Ductal, Breast
- Carcinoma, Endometrioid
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Carcinosarcoma
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Choriocarcinoma
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Cystadenocarcinoma
- Cystadenocarcinoma, Mucinous
- Cystadenocarcinoma, Serous
- Deglutition Disorders
- Drug-Related Side Effects and Adverse Reactions
- Endometrial Neoplasms
- Epstein-Barr Virus Infections
- Erectile Dysfunction
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Esophagitis
- Fallopian Tube Neoplasms
- Fatigue
- Fibrosis
- Gestational Trophoblastic Disease
- Glioblastoma
- Glioma
- Gliosarcoma
- Granulosa Cell Tumor
- Head and Neck Neoplasms
- Hydatidiform Mole
- Hypersensitivity
- Infertility
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leiomyosarcoma
- Leydig Cell Tumor
- Lip Neoplasms
- Lung Neoplasms
- Lymphoma
- Mesothelioma
- Mixed Tumor, Mullerian
- Mouth Neoplasms
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Nervous System Neoplasms
- Neurotoxicity Syndromes
- Oligodendroglioma
- Oropharyngeal Neoplasms
- Ovarian Neoplasms
- Pancreatic Intraductal Neoplasms
- Pancreatic Neoplasms
- Peritoneal Neoplasms
- Precancerous Conditions
- Prostatic Neoplasms
- Radiation Pneumonitis
- Rectal Neoplasms
- Salivary Gland Neoplasms
- Sarcoma
- Sarcoma, Endometrial Stromal
- Sertoli-Leydig Cell Tumor
- Sex Cord-Gonadal Stromal Tumors
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Thyroid Carcinoma, Anaplastic
- Thyroid Diseases
- Thyroid Neoplasms
- Tongue Neoplasms
- Trophoblastic Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Vaginal Neoplasms
- Virus Diseases
- Vulvar Neoplasms
Recent trials (50)
- NCT07198074OfficialPhase 3Dec 15, 2025
- NCT07166406Lead sponsorPhase 3Nov 27, 2025
- NCT07195734OfficialPhase 2Nov 14, 2025
- NCT07061977OfficialPhase 3Nov 5, 2025
- NCT06958328OfficialPhase 3Aug 21, 2025
- NCT06958328Lead sponsorPhase 3Aug 21, 2025
- NCT07097142Lead sponsorPhase 3Aug 14, 2025
- NCT06393751OfficialPhase 1/Phase 2May 2, 2025
- NCT06770582OfficialPhase 2Mar 7, 2025
- NCT06580314Lead sponsorPhase 3Jan 16, 2025
- NCT06592924CollaboratorPhase 3Jan 15, 2025
- NCT06568172OfficialPhase 3Jan 9, 2025
- NCT07224048CollaboratorPhase 4Nov 6, 2024
- NCT06532279OfficialPhase 2Oct 30, 2024
- NCT06532279Lead sponsorPhase 2Oct 30, 2024
Details
- Founded
- Philadelphia, PA, US Mar 1, 2014
- Last known activity
- Dec 15, 2025
Notes
brings together the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)—each recognized internationally as a research leader. "independent but collaborative entities" - purpose: conduct of multi-institutional research trials